Experienced in Head Lice

Cyrielle Caussy

Lyon, FR 
Experienced in Head Lice
Lyon, FR 
OverviewLocationsClinical Research

Overview

Cyrielle Caussy practices in Lyon, France. Ms. Caussy is rated as an Experienced expert by MediFind in the treatment of Head Lice. Her top areas of expertise are Non-Alcoholic Fatty Liver Disease, Cirrhosis, Familial Hypertriglyceridemia, and Nonalcoholic Steatohepatitis (NASH).

Her clinical research consists of co-authoring 74 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Head Lice.

Gender
Female

Locations

Lyon, France
Other Locations
Pierre-la-treiche, 69495, France
Auvergny, France
Oullins, France
Villeurbanne, 69100, France
Fédération D'endocrinologie, Maladies Métaboliques, Diabète Et Nutrition, 28 Avenue Doyen Lépine, Bron, 69677, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Screening for NAFLD-related Advanced Fibrosis in High Risk popuLation: Optimization of the Diabetology Pathway Referral Using Combinations of Non-invAsive Biological and elastogRaphy paramEters
Screening for NAFLD-related Advanced Fibrosis in High Risk popuLation: Optimization of the Diabetology Pathway Referral Using Combinations of Non-invAsive Biological and elastogRaphy paramEters
Enrollment Status: Completed
Publish Date: February 11, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
Liver and Metabolic Effects of Insulin Pump Therapy in a Population of Type 2 Diabetics with Non-alcoholic Hepatic Steatosis
Liver and Metabolic Effects of Insulin Pump Therapy in a Population of Type 2 Diabetics with Non-alcoholic Hepatic Steatosis
Enrollment Status: Completed
Publish Date: October 17, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
View 2 Less Clinical Trials

74 Total Publications

N-acetyl-phenylalanine induces hepatic steatosis in MASLD by disrupting ER-mitochondria calcium coupling and mitochondrial lipid oxidation.
N-acetyl-phenylalanine induces hepatic steatosis in MASLD by disrupting ER-mitochondria calcium coupling and mitochondrial lipid oxidation.
Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Caussy's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile